Products
Enfortumab Vedotin Biosimilar Antibody-Drug Conjugate (Nectin-4) for Research
Cat No.: GMP-Bios-INN-833
Pre-made Enfortumab Vedotin benchmark antibody (Whole mAb ADC, anti-PVRL4/NECTIN4 therapeutic antibody, Anti-EDSS1/LNIR/PRR4/nectin-4 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Order Information
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
| Catalog No. | Package | Price(In USD) |
|---|---|---|
| GMP-Bios-INN-833-1mg | 1mg | 4635 |
| GMP-Bios-INN-833-10mg | 10mg | |
| GMP-Bios-INN-833-100mg | 100mg | |
| GMP-Bios-INN-833-xmg | ≥100mg |
Product Details
| Products Name (INN Index) | Pre-Made Enfortumab Vedotin Biosimilar, Whole Mab Adc, Anti-PVRL4/NECTIN4 Antibody: Anti-EDSS1/LNIR/PRR4/nectin-4 therapeutic antibody Drug Conjugate |
| INN Name | Enfortumab Vedotin |
| Target | PVRL4/NECTIN4 |
| Format | Whole mAb ADC |
| Derivation | human |
| Species Reactivity | human |
| CH1 Isotype | IgG1 - kappa |
| VD LC | IgG1 - kappa |
| Highest_Clin_Trial (Jan '20) | |
| Est. Status | |
| 100% SI Structure | |
| 99% SI Structure | |
| 95-98% SI Structure | |
| Year Proposed | |
| Year Recommended | |
| Companies | Seattle genetics, Inc. (Bothell WA USA) / Agensys (Santa Monica CA USA) / Astellas Pharma US, Inc. (Northbrook IL USA) |
| Conditions Approved | |
| Conditions Active | |
| Conditions Discontinued | |
| Development Tech | 0 |
